Clinical trial / 2016
Taurine supplementation for 12 weeks significantly reduced blood pressure and improved vascular function in prehypertensive individuals.
A randomized, double-blind, placebo-controlled study assigned 120 prehypertensive individuals to receive 1.6 g per day of taurine or a placebo for 12 weeks. Taurine supplementation significantly decreased clinic systolic BP (mean reduction: 7.2 vs. 2.6 mm Hg for placebo) and diastolic BP (4.7 vs. 1.3 mm Hg), as well as ambulatory systolic BP (3.8 vs. 0.3 mm Hg) and diastolic BP (3.5 vs. 0.6 mm Hg). Supplementation also improved endothelium-dependent and endothelium-independent vasodilation and increased plasma H2S and taurine concentrations, which negatively correlated with BP changes.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 120 eligible prehypertensive individuals
- What was measured
- Clinic and 24-hour ambulatory blood pressure, and vascular function
THE PAPER
Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study.
Sun Q, Wang B, Li Y, Sun F, Li P, Xia W, Zhou X, Li Q, Wang X, Chen J, Zeng X, Zhao Z, He H, Liu D, Zhu Z. Hypertension, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.